Company Overview
Bridgewest Group is a Miami headquartered investment group. It is the parent of LumaCina, the Perth based supplier of sterile injectable pharmaceuticals.
Executive Moves reported in July 2026 that LumaCina, a Bridgewest Group portfolio company, had appointed Gary Bird as Chief Executive Officer, with Executive Chair Mark Crotty continuing to oversee long term strategy and platform development.
This page is a light profile compiled from Executive Moves coverage. Founding detail, scale markers, portfolio breadth and ownership have not yet been confirmed from a primary source and will be added as they are verified.
Recent Leadership News
Executive Moves has not yet published a leadership appointment at Bridgewest Group. This section updates as coverage is added.
Facts compiled by Executive Moves from publicly available news and press releases on 16 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the Bridgewest Group team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
